Paradromics received regulatory approval to test its BCI device in a small clinical trial to assess its safety and efficacy.

Paradromics and Neuralink are leading the race in developing advanced brain implants. Reports highlight differences in ...

FDA approves first human trial for Paradromics' brain-computer interface that could restore speech for paralyzed patients ...

Fara-7B is our first agentic small language model for computer use. This experimental model includes robust safety measures ...

These automated agents can process sensor data, make decisions, and execute actions without explicit commands from developers. Unlike apps that are trapped in phones, they can be embedded in homes and ...

The model can interpret on-screen visuals, automate tasks directly on the device, and give enterprises a more affordable ...

Microsoft has announced a new small language model called Fara-7B, which can be used to perform agentic tasks directly on the ...

Paradromics Inc., a neurotechnology company developing the highest data-rate brain-computer interface (BCI) platform, today announced the US FDA has granted Investigational Device Exemption (IDE) ...

Austin-based neurotechnology Paradromics announced that it has received FDA approvals to start its clinical trials.

Paradromics announced that it received FDA investigational device exemption (IDE) to begin a study of its brain-computer ...

Scientists have developed better devices to help people with disabilities regain function. These findings will be presented at Neuroscience 2025, the annual meeting of the Society for Neuroscience and ...